Acyclovir Cream Dosage for Herpes Simplex
Acyclovir cream (5%) should be applied 5 times daily for 5 days, but oral acyclovir is strongly preferred over topical formulations because topical therapy is substantially less effective and its use is discouraged. 1
Why Topical Acyclovir Is Not Recommended
- The CDC explicitly states that topical acyclovir therapy is substantially less effective than oral formulations and its use is discouraged for treating herpes simplex infections. 1
- Topical acyclovir provides no improvement in systemic symptoms and is significantly less effective than oral therapy. 2
- Oral antiviral medications are significantly more effective than topical formulations for treating cold sores and genital herpes. 3
Recommended Oral Alternatives (Preferred Over Cream)
For Recurrent Herpes Labialis (Cold Sores):
- Acyclovir 800 mg orally twice daily for 5 days (most convenient, equivalent efficacy) 3
- Acyclovir 400 mg orally 3 times daily for 5 days 3, 4
- Acyclovir 200 mg orally 5 times daily for 5 days 3
For First Episode Genital Herpes:
For Recurrent Genital Herpes:
- Acyclovir 800 mg orally twice daily for 5 days 1
- Acyclovir 400 mg orally 3 times daily for 5 days 1
- Acyclovir 200 mg orally 5 times daily for 5 days 1
Critical Timing Considerations
- Treatment must be initiated during prodrome or within 2 days of lesion onset for maximum benefit. 3, 2
- Starting therapy after this window significantly reduces effectiveness, and most immunocompetent patients with recurrent disease experience limited benefit from delayed therapy. 3
- Early treatment can reduce pain duration by 36% and healing time by 27% when started in the prodrome or erythema stage. 5
If Topical Acyclovir Cream Must Be Used
When oral therapy is not feasible and topical acyclovir 5% cream is the only option:
- Apply 5 times daily for 5 days, starting at earliest sign of recurrence 6, 7
- The combination product containing 5% acyclovir plus 1% hydrocortisone cream shows superior efficacy to acyclovir cream alone, reducing both ulcerative and nonulcerative recurrences. 6, 7
- Topical acyclovir may speed healing in immunocompromised patients with chronic ulcerative herpetic lesions when systemic therapy is not desired. 8
Special Populations Requiring Oral or IV Therapy
Immunocompromised Patients:
- Require more aggressive therapy with acyclovir 400 mg orally 3-5 times daily or IV administration. 1, 9
- May have prolonged episodes with extensive disease requiring IV acyclovir 5-10 mg/kg every 8 hours. 1
Severe Disease:
- IV acyclovir 5-10 mg/kg every 8 hours for 5-7 days for hospitalized patients with disseminated infection, pneumonitis, hepatitis, or CNS complications. 1
Important Caveats
- Acyclovir neither eradicates latent virus nor affects subsequent risk, frequency, or severity of recurrences after discontinuation. 1, 3
- Patients should abstain from activities that might spread the virus while lesions are present, though transmission can occur during asymptomatic periods. 3, 2
- Most immunocompetent patients with recurrent disease experience limited benefit from therapy overall. 1, 3